StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2021 it was -$4.01M. The highest annual figure on record is -$1.34M in fiscal 2010.

Annual ebitda

PeriodPeriod endValueChange
FY2021Dec 31, 2021-$4.01M–
FY2020Dec 31, 2020-$3.10M–
FY2012Dec 31, 2012-$2.75M–
FY2011Dec 31, 2011-$2.31M–
FY2010Dec 31, 2010-$1.34M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$4.30M–
Q2 FY2025Jun 30, 2025-$4.79M–
Q1 FY2025Mar 31, 2025-$3.49M–
Q3 FY2024Sep 30, 2024-$3.24M–
Q2 FY2024Jun 30, 2024-$4.48M–
Q1 FY2024Mar 31, 2024-$2.95M–
Q1 FY2023Mar 31, 2023-$1.28M–

More Glucotrack figures

See a number that looks wrong?